Cadrenal Therapeutics
CVKD
CVKD
17 hedge funds and large institutions have $824K invested in Cadrenal Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
33% less capital invested
Capital invested by funds: $1.22M → $824K (-$399K)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$48.7K | |
| 2 | +$44K | |
| 3 | +$28.5K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.27K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.02K |
Top Sellers
| 1 | -$121K | |
| 2 | -$14.9K | |
| 3 | -$10.4K | |
| 4 |
JP Morgan Chase
New York
|
-$1.76K |
| 5 |
PWA
Physician Wealth Advisors
Midvale,
Utah
|
-$917 |